KURA ONCOLOGY INC (KURA) Stock Balance Sheet
NASDAQ:KURA - Nasdaq - US50127T1097 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 51.27M | 224.46M | 37.32M | 51.80M | 90.70M | |||
| Marketable Securities | 606.92M | 502.93M | 386.64M | 386.20M | 427.30M | |||
| Receivables | 48.75M | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 17.26M | 17.43M | 8.52M | 8.40M | 4.30M | |||
| Total Current Assets | 724.20M | 744.83M | 432.48M | 446.40M | 522.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 10.49M | 7.49M | 8.85M | 6.40M | 8.20M | |||
| Other Non-Current Assets | 9.08M | 7.84M | 7.60M | 3.50M | 3.50M | |||
| Total Non-Current Assets | 19.57M | 15.33M | 16.45M | 9.90M | 11.80M | |||
| TOTAL ASSETS | 743.76M | 760.16M | 448.94M | 456.30M | 534.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 1.92M | 2.61M | N/A | N/A | 0.00 | |||
| Accrued Expenses | 40.10M | 48.30M | 32.96M | 22.50M | 19.20M | |||
| Accounts Payable | 4.61M | 1.47M | 2.30M | 1.50M | 3.20M | |||
| Other Current Liabilities | 43.13M | 26.33M | N/A | N/A | N/A | |||
| Total Current Liabilities | 89.77M | 78.71M | 35.26M | 24.10M | 22.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 7.65M | 6.92M | 9.33M | 9.20M | 0.00 | |||
| Other Non-Current Liabilities | 281.94M | 260.89M | 7.07M | 2.80M | 5.00M | |||
| Total Non-Current Liabilities | 289.59M | 267.81M | 16.40M | 11.90M | 4.90M | |||
| TOTAL LIABILITIES | 379.36M | 346.52M | 51.66M | 36.00M | 27.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -952.85M | -895.42M | -721.44M | -568.80M | -433.00M | |||
| Additional Paid In Capital | 1.32B | 1.31B | 1.12B | 997.10M | 941.40M | |||
| Common Shares | 8.00K | 8.00K | 7.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 974.00K | 764.00K | -1.27M | -8.00M | -1.80M | |||
| Shares Outstanding | 80.78M | 78.23M | 74.35M | 68.30M | 66.60M | |||
| Tangible Book Value per Share | 4.51 | 5.29 | 5.34 | 6.15 | 7.61 | |||
| Total Shareholders' Equity | 364.41M | 413.64M | 397.27M | 420.30M | 506.60M | |||
| TOTAL LIABILITIES AND EQUITY | 743.76M | 760.16M | 448.94M | 456.30M | 534.10M | |||
| Statistics | ||||||||
| Debt/Equity | 0.02 | 0.02 | 0.02 | 0.02 | N/A | |||
| Current Ratio | 8.07 | 9.46 | 12.26 | 18.52 | 23.21 | |||
| Return On Assets (ROA) | -24.45% | -22.89% | -34.00% | -29.77% | -24.43% | |||
| Return On Equity (ROE) | -49.91% | -42.06% | -38.42% | -32.32% | -25.75% | |||
All data in USD , ROIC based on taxRate of 0.21